Intra- and inter-generic plasmid-mediated spread of cephalosporin and aminoglycoside resistance amongst Klebsiella aerogenes K41 and other enterobacteria

International Journal of Antimicrobial Agents

Volumn 17, Issue 2, 2001, Pages 123-129

  Verma, A ^a   Desai, N ^a   Shannon, K ^a   Philpott Howard, J ^a   Hill, R L R ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Intergeneric plasmid transfer; Klebsiella aerogenes; SHV 5; TEM 1

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; SULFAMETHOXAZOLE; TEMOCILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; ENTEROBACTERIACEAE; HUMAN; KLEBSIELLA AEROGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PRIORITY JOURNAL;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; CONJUGATION, GENETIC; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PLASMIDS;

EID: 0035139587     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00324-1     Document Type: Article

References (45)

1. Investigation of β-lactamase, stability of ceftazidime and eight new cephalosporin antibiotics
2. Emergence of resistance during therapy with newer β-lactam antibiotics: role of inducible β-lactamases and implication for future
3. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
4. Transferable enzymatic resistance to third generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae
5. Transferable resistance to third generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-l, a novel beta-lactamase
6. Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a transferable enzymatic resistance to third generation cephalosporins and aztreonam
7. Klebsiella pneumoniae and other Enterobacteriacae producing novel plasmid mediated beta lactamases markedly active against third generation cephalosporins: epidemiologic studies
8. Extended broad spectrum beta lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns
9. Novel beta-lactamase in clinical isolates of Klebsiella pneumoniae conferring unusual resistance to beta-lactam antibiotics
10. Importation of organisms producing broad-spectrum SHV-group β-lactamases into the United Kingdom
11. Outbreak of infection in two hospitals caused by a strain of Klebsiella pneumoniae resistant to cefotaxime and ceftazidime
12. Hospital outbreak of Klebsiella pneumoniae resistant to broad spectrum cephalosporins and β-lactam β-lactamase inhibitor combination by hyperproduction of SHV-5 β-lactamase
13. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece
14. Klebsiella pneumoniae infections in Greek hospitals; dissemination of plasmids encoding an SHV-5 type beta-lactamase
15. Detection of SHV-5 extended spectrum beta-lactamase in Klebsiella pneumoniae strains isolated in Italy
16. Ceftazidime resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM and SHV-5-type extended-spectrum β-lactamases
17. Nosocomial outbreak of Klebsiella infection resistant to late generation cephalosporins
18. Molecular epidemiology of an SHV-5 extended spectrum beta-lactamase in Enterobacteriaceae isolated from infants in a neonatal intensive care unit
19. Novel plasmid mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae
20. Failure of ceftazidime amikacin therapy for bacteraemia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum β-lactamase
21. SHV-5, a novel SHV-type β-lactamase that hydrolyses broad-spectrum cephalosporins and monobactams
22. Synergy between clavulanic acid and newer beta-lactamases in clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins
23. More extended-spectrum beta-lactamases
24. Sequential emergence of multi-resistant Klebsiella pneumoniae in Bahrain
25. Properties of plasmids responsible for production of extended spectrum β-lactamases
26. Characterisation of an SHV-5 related extended broad-spectrum beta-lactamase in Enterobacteriaceae from Western Australia
27. Outbreak of TEM-24 producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum β-lactamase to other members of the family Enterobacteriaceae
28. Survey of the prevelance of β-lactamases amongst 1000 Gram-negative bacilli isolated consecutively at the Royal London Hospital
29. Resistance to cefotaxime and seven other β-lactamases in members of the family Enterobacteriaceae: a 3-year survey in France
30. Dissemination of the novel plasmid-mediated β-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by β-lactamase inhibitors
31. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility
32. Translocation of antibiotic resistance determinants including an extended-spectrum beta-lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli
33. Characterization of plasmids and plasmid associated determinants of Yersinia enterocolitica pathogenesis
34. Transferable resistance to extended spectrum beta-lactamase; a major threat or a minor inconvenience?
35. Nosocomial Klebsiella infections: intestinal colonisation as a reservoir
36. Aspects of plasmid mediated antibiotic resistance and epidemiology of Klebsiella species
37. Nucleotide sequence and phylogeny of SHV-2 beta-lactamase
38. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta-lactamase: parallel outbreaks due to multiple plasmid transfer
39. New mechanisms of bacterial resistance to antimicrobial agents
40. Comparative study of five plasmid mediated ceftazidimases isolated in Klebsiella pneumoniae
41. Klebsiella pneumoniae strains more resistant to ceftazidime than to other third-generation cephalosporins
42. Bactericidal effect of beta-lactams and amikacin alone or in association against Klebsiella pneumoniae producing extended spectrum beta-lactamase
43. In vitro activity of meropenem and seven other beta-lactam antibiotics against K. pneumoniae and enterobacteriaceae producing beta-lactamases with extended spectrum
44. Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae
45. Carbapenem-hydrolysis IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore